Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Partnerselskabet Amalieklinikken 2021 Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   1.7% 1.1% 4.7% 1.1% 1.6% 31.6% 11.8% 11.6%   Credit score (0-100)   75 86 47 85 74 1 19 20   Credit rating   A A BBB A A C BB BB   Credit limit (kDKK)   10.8 426.0 0.0 473.8 25.3 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   18,622 22,914 19,370 22,638 27,312 15,202 0.0 0.0   EBITDA   4,206 1,915 274 2,595 4,324 61,065 0.0 0.0   EBIT   3,158 1,055 -737 1,653 3,337 31,408 0.0 0.0   Pre-tax profit (PTP)   3,014.6 950.0 -807.9 1,577.3 3,248.4 31,913.2 0.0 0.0   Net earnings   3,014.6 950.0 -807.9 1,577.3 3,248.4 31,913.2 0.0 0.0   Pre-tax profit without non-rec. items   3,015 950 -808 1,577 3,248 31,913 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Tangible assets total   2,608 3,679 3,309 2,827 2,125 0.0 0.0 0.0   Shareholders equity total   3,313 4,263 3,455 5,033 6,381 31,294 3,193 3,193   Interest-bearing liabilities   237 26.4 8.8 4.3 8.6 7,004 0.0 0.0   Balance sheet total (assets)   5,672 6,569 5,678 7,480 10,722 39,989 3,193 3,193   Net Debt   -1,333 -909 -593 -3,229 -6,518 7,004 -3,193 -3,193     See the entire balance sheet 1000.0 Volume  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   18,622 22,914 19,370 22,638 27,312 15,202 0.0 0.0   Gross profit growth   0.0% 23.0% -15.5% 16.9% 20.6% -44.3% -100.0% 0.0%   Employees   12 16 14 18 20 20 0 0   Employee growth %   0.0% 33.3% -12.5% 28.6% 11.1% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   5,672 6,569 5,678 7,480 10,722 39,989 3,193 3,193   Balance sheet change%   0.0% 15.8% -13.6% 31.7% 43.3% 272.9% -92.0% 0.0%   Added value   4,206.0 1,915.1 274.0 2,595.3 4,278.9 61,065.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   2,703 -75 -1,668 -1,710 -1,974 -31,783 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 -1.0 1.0 2.0 3.0 0.0 0.0   1000.0 Profitability  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   17.0% 4.6% -3.8% 7.3% 12.2% 206.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   55.7% 17.2% -11.9% 25.2% 36.8% 126.2% 0.0% 0.0%   ROI %   89.0% 26.9% -18.8% 39.0% 58.7% 143.2% 0.0% 0.0%   ROE %   91.0% 25.1% -20.9% 37.2% 56.9% 169.4% 0.0% 0.0%   1000.0 Solidity  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Equity ratio %   58.9% 65.3% 62.2% 68.5% 59.8% 78.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -31.7% -47.4% -216.5% -124.4% -150.8% 11.5% 0.0% 0.0%   Gearing %   7.1% 0.6% 0.3% 0.1% 0.1% 22.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   123.6% 79.7% 440.8% 1,233.0% 1,627.8% 2.5% 0.0% 0.0%   1000.0 Liquidity  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Quick Ratio   0.7 0.5 0.4 1.6 2.0 4.6 0.0 0.0   Current Ratio   0.8 0.7 0.6 1.7 2.2 4.6 0.0 0.0   Cash and cash equivalent   1,569.8 935.1 602.0 3,233.3 6,527.0 0.0 0.0 0.0   1000.0 Capital use efficiency  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -446.4 -799.6 -960.3 1,586.7 4,386.8 31,294.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   350 120 20 144 214 3,053 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   350 120 20 144 216 3,053 0 0   EBIT / employee   263 66 -53 92 167 1,570 0 0   Net earnings / employee   251 59 -58 88 162 1,596 0 0